Assignee

Dexcom, Inc.

Patents = 948

Trademarks = 23

Forward Citations = 69,506

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

428 inventors (with patents filed for the assignee):

DexCom, Inc. is a leading provider of continuous glucose monitoring (CGM) systems for diabetes management. They develop and market innovative CGM systems that help patients and healthcare professionals effectively manage diabetes. DexCom's CGM technology enables real-time monitoring of glucose levels, allowing patients to make informed decisions about their treatment and improve overall diabetes control. With a commitment to advancing diabetes care, DexCom focuses on developing innovative solutions to improve the lives of people with diabetes.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com